相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。c-Myc directly targets an over-expression of pyruvate carboxylase in highly invasive breast cancer
Udom Lao-On et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Make your best BET: The emerging role of BET inhibitor treatment in malignant tumors
Oliver Bechter et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Opposing Functions of BRD4 Isoforms in Breast Cancer
Shwu-Yuan Wu et al.
MOLECULAR CELL (2020)
Considerations and Challenges in Studying Liquid-Liquid Phase Separation and Biomolecular Condensates
Simon Alberti et al.
CELL (2019)
CDK9: a signaling hub for transcriptional control
Curtis W. Bacon et al.
TRANSCRIPTION-AUSTIN (2019)
Coactivator condensation at super-enhancers links phase separation and gene control
Benjamin R. Sabari et al.
SCIENCE (2018)
Mediator and RNA polymerase II clusters associate in transcription-dependent condensates
Won-Ki Cho et al.
SCIENCE (2018)
Phase-separation mechanism for C-terminal hyperphosphorylation of RNA polymerase II
Huasong Lu et al.
NATURE (2018)
Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4
Francesca Zanconato et al.
NATURE MEDICINE (2018)
Drug Discovery Targeting Bromodomain-Containing Protein 4
Zhiqing Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Phase separation drives heterochromatin domain formation
Amy R. Strom et al.
NATURE (2017)
Targeted Degradation of BET Proteins in Triple-Negative Breast Cancer
Longchuan Bai et al.
CANCER RESEARCH (2017)
Droplet organelles?
Edward M. Courchaine et al.
EMBO JOURNAL (2016)
Bromodomain 4: a cellular Swiss army knife
Ballachanda N. Devaiah et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
Shaokun Shu et al.
NATURE (2016)
Phase Separation by Low Complexity Domains Promotes Stress Granule Assembly and Drives Pathological Fibrillization
Amandine Molliex et al.
CELL (2015)
Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4
Jing Lu et al.
CHEMISTRY & BIOLOGY (2015)
Formation and Maturation of Phase-Separated Liquid Droplets by RNA-Binding Proteins
Yuan Lin et al.
MOLECULAR CELL (2015)
A Natural Product from Polygonum cuspidatum Sieb. Et Zucc. Promotes Tat-Dependent HIV Latency Reversal through Triggering P-TEFb's Release from 7SK snRNP
Cong Wang et al.
PLOS ONE (2015)
MYC: connecting selective transcriptional control to global RNA production
Theresia R. Kress et al.
NATURE REVIEWS CANCER (2015)
Liquid-Liquid Phase Separation in Biology
Anthony A. Hyman et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 30 (2014)
The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
Junwei Shi et al.
MOLECULAR CELL (2014)
LARP7 suppresses P-TEFb activity to inhibit breast cancer progression and metastasis
Xiaodan Ji et al.
ELIFE (2014)
Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma
Bjoern Chapuy et al.
CANCER CELL (2013)
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Jakob Loven et al.
CELL (2013)
Viral-Host Interactions That Control HIV-1 Transcriptional Elongation
Huasong Lu et al.
CHEMICAL REVIEWS (2013)
Toward the Molecular Mechanism(s) by Which EGCG Treatment Remodels Mature Amyloid Fibrils
Fernando L. Palhano et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation
Zichong Li et al.
NUCLEIC ACIDS RESEARCH (2013)
RNA Polymerase II Elongation Control
Qiang Zhou et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 81 (2012)
BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia
Christopher J. Ott et al.
BLOOD (2012)
Bromodomain and Extra-terminal (BET) Bromodomain Inhibition Activate Transcription via Transient Release of Positive Transcription Elongation Factor b (P-TEFb) from 7SK Small Nuclear Ribonucleoprotein
Koen Bartholomeeusen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
BET bromodomain inhibition as a novel strategy for reactivation of HIV-1
Camellia Banerjee et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
BET domain co-regulators in obesity, inflammation and cancer
Anna C. Belkina et al.
NATURE REVIEWS CANCER (2012)
Peptoid ligands that bind selectively to phosphoproteins
Di Cai et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Johannes Zuber et al.
NATURE (2011)
Targeting MYC dependence in cancer by inhibiting BET bromodomains
Jennifer A. Mertz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Basic biochemical mechanisms behind the health benefits of polyphenols
Cesar G. Fraga et al.
MOLECULAR ASPECTS OF MEDICINE (2010)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
A la-related protein modulates 7SK snRNP integrity to suppress P-TEFb-dependent transcriptional elongation and tumorigenesis
Nanhai He et al.
MOLECULAR CELL (2008)
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Dagmar E. Ehrnhoefer et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription
MK Jang et al.
MOLECULAR CELL (2005)
Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein brd4
ZY Yang et al.
MOLECULAR CELL (2005)
Prostratin antagonizes HIV latency by activating NF-κB
SA Williams et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)